These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18816632)

  • 1. Absence of ESR1 amplification in a series of breast cancers.
    Adélaïde J; Finetti P; Charafe-Jauffret E; Wicinski J; Jacquemier J; Sotiriou C; Bertucci F; Birnbaum D; Chaffanet M
    Int J Cancer; 2008 Dec; 123(12):2970-2. PubMed ID: 18816632
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
    Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
    J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESR1 gene amplification in breast cancer: a common phenomenon?
    Horlings HM; Bergamaschi A; Nordgard SH; Kim YH; Han W; Noh DY; Salari K; Joosse SA; Reyal F; Lingjaerde OC; Kristensen VN; Børresen-Dale AL; Pollack J; van de Vijver MJ
    Nat Genet; 2008 Jul; 40(7):807-8; author reply 810-2. PubMed ID: 18583965
    [No Abstract]   [Full Text] [Related]  

  • 4. ESR1 amplification in endometrial carcinomas: hope or hyperbole?
    Tan DS; Lambros MB; Marchiò C; Reis-Filho JS
    J Pathol; 2008 Nov; 216(3):271-4. PubMed ID: 18788074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
    Holst F; Stahl PR; Ruiz C; Hellwinkel O; Jehan Z; Wendland M; Lebeau A; Terracciano L; Al-Kuraya K; Jänicke F; Sauter G; Simon R
    Nat Genet; 2007 May; 39(5):655-60. PubMed ID: 17417639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.
    Ooi A; Inokuchi M; Harada S; Inazawa J; Tajiri R; Kitamura SS; Ikeda H; Kawashima H; Dobashi Y
    J Pathol; 2012 May; 227(1):8-16. PubMed ID: 22170254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.
    Soysal SD; Kilic IB; Regenbrecht CR; Schneider S; Muenst S; Kilic N; Güth U; Dietel M; Terracciano LM; Kilic E
    Breast Cancer Res Treat; 2015 Jun; 151(3):709-15. PubMed ID: 25981900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESR1 gene amplification in breast cancer: a common phenomenon?
    Vincent-Salomon A; Raynal V; Lucchesi C; Gruel N; Delattre O
    Nat Genet; 2008 Jul; 40(7):809; author reply 810-2. PubMed ID: 18583967
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
    Nielsen KV; Ejlertsen B; Müller S; Møller S; Rasmussen BB; Balslev E; Lænkholm AV; Christiansen P; Mouridsen HT
    Breast Cancer Res Treat; 2011 Jun; 127(2):345-55. PubMed ID: 20556506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?
    Petroni S; Addati T; Mattioli E; Caponio MA; Quero C; Rubini V; Giotta F; Simone G
    Arch Pathol Lab Med; 2012 Sep; 136(9):993-1000. PubMed ID: 22938586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
    Moelans CB; Holst F; Hellwinkel O; Simon R; van Diest PJ
    PLoS One; 2013; 8(12):e84189. PubMed ID: 24367641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESR1 amplification in breast cancer: controversy resolved?
    Albertson DG
    J Pathol; 2012 May; 227(1):1-3. PubMed ID: 22322671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflicting evidence on the frequency of ESR1 amplification in breast cancer.
    Albertson DG
    Nat Genet; 2008 Jul; 40(7):821-2. PubMed ID: 18583976
    [No Abstract]   [Full Text] [Related]  

  • 16. ESR1 gene amplification in breast cancer: a common phenomenon?
    Reis-Filho JS; Drury S; Lambros MB; Marchio C; Johnson N; Natrajan R; Salter J; Levey P; Fletcher O; Peto J; Ashworth A; Dowsett M
    Nat Genet; 2008 Jul; 40(7):809-10; author reply 810-2. PubMed ID: 18583966
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and Biological Significance of
    Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR1 gene amplification in breast cancer: a common phenomenon?
    Brown LA; Hoog J; Chin SF; Tao Y; Zayed AA; Chin K; Teschendorff AE; Quackenbush JF; Marioni JC; Leung S; Perou CM; Neilsen TO; Ellis M; Gray JW; Bernard PS; Huntsman DG; Caldas C
    Nat Genet; 2008 Jul; 40(7):806-7; author reply 810-2. PubMed ID: 18583964
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential therapeutic target for triple-negative breast cancer.
    Gilbert JA
    Lancet Oncol; 2012 Aug; 13(8):e330. PubMed ID: 23024992
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
    Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
    Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.